Triiodothyronine and thyroxine induce a 3-fold increase in the rate of growth of GH, cells in culture.
[125ljthyroxine to cellular fractions after incubation with intact cells in serum-free medium. High-affinity, lowcapacity binding sites for the hormones were demonstrated in nuclear but not in mitochondrial or cytosol fractions. Chromatographic analysis of the bound nuclear radioactivity from cells incubated with [121I]thyroxine demonstrated 97% thyroxine, 1% iodide, and 1% triiodothyronine. Apparent equilibrium dissociation constants, determined by Scatchard analysis, were 29 pM for triidothyronine and 260 pM for thyroxine. The maximal binding capacity was identical for both hormones, with about 5000 sites per cell nucleus. [inIlThyroxine binding was competitively inhibited by triiodothyronine. These data suggest that triiodothyronine and thyroxine interact with identical nuclear receptors, and that conversion of thyroxine to triiodothyronine may not be a prerequisite for biologic activity. Similar high-affinity, low-capacity nuclear binding sites were also demonstrated by incubation of [1251ltriidothyronine directly with isolated nuclei.
Incubation of cells with increasing concentrations of nonradioactive triidothyronine results in a subsequent increase in binding when [125Iltriiodothyronine is then incubated directly with isolated nuclei. This result suggests that nuclear receptors are not fixed, but increase after exposure of intact cells to hormone. This increase in nuclear receptor content may result from the transfer of an unstable cytosol receptor to the nucleus.
Thyroid hormones affect the growth, development, and metabolism of virtually all tissues of higher organisms (1) . In spite of extensive in vivo studies, the mechanism of action of thyroxine (T4) and triiodothyronine (T3) has not been determined. In addition, recent studies have demonstrated that T4 is converted to T3 by deiodination in vivo (2, 
3).
These studies have revitalized the concept that T4 functions as a prohormone and all its biologic activity results from its conversion to T3 in vivo (4) .
We recently demonstrated that T3 and T4 induce a maximal 3-fold increase in the rates of growth and glucose utilization of GH, cells (a rat pituitary tumor cell line) in culture (5) . These effects are induced by concentrations of hormone at physiologic' levels in humans and other species as well as concentrations observed in thyrotoxic humans.' Early effects of T3 and T4 on increasing RNA polymerase activity, nucleoside transport, and glucose utilization can be detected within 2-3 hr after incubation of hormone with intact cells (6) . We examined the binding of T3 and T4 to various subcellular components of GH, cells. Saturable binding sites with affinities for T3 and T4 that correlate well enough with biologic dose-response relationships to be putative "receptors" for these hormones were detected only in the nuclear fraction. The interaction of hormone with these "receptors" can be demonstrated by incubation either with intact cells or with isolated nuclei.
MATERIALS AND METHODS
Cell Suspensions and Media. GH, cells were obtained from the American Type Culture Collection. Cell cultures are routinely grown in 95% air-5%0 CO2 with Ham's F-10 medium supplemented to 15% with horse serum and to 2.5% with fetal-calf serum (Grand Island Biological Co., Grand Island, N.Y.). The hormone concentrations in these sera are physiologic and are about 2 nM for T3 and 100 nM for T4, as determined by gas-liquid chromatography and specific radioimmunoassay (5). For hormone-binding studies, the medium was replaced with hypothyroid medium (Ham's F-10 medium supplemented to 10%o with hypothyroid calf serum obtained from a thyroidectomized calf, Rockland Farms, Pa.) and the cultures were incubated for 24-48 hr to deplete the cells of hormone. The hormone concentrations in the thyroidectomized calf serum are 0.3 nM for T3 and 3 nM for T4 (5, 7) .
Binding Studies with Intact Cells. For binding studies, the cells were harvested in the late logarithmic phase of growth with a rubber policeman and centrifuged at 500 X g for 5 min. The cell pellet was washed three times with 10 1.1 mM MgC12-0.5% Triton X-100 at pH 7.85 at 250) (8, 9) . Triton X-100 was obtained from Packard. Although nuclei isolated by centrifugation through 2.2 M sucrose appeared to be generally free of cytoplasmic contamination as determined by staining and phase-contrast microscopy, these nuclei required one to two additional treatments with STMTriton buffer to eliminate a significant amount of low-affinity binding (unpublished data). The nuclear bound radioactivity did not decrease further with additional treatment with STM-Triton buffer. Both procedures isolated nuclei with protein/DNA ratios of about 2 and RNA/DNA ratios of 0.22. Protein, DNA, and RNA were determined (10) (11) (12) .
Nuclear binding was also demonstrated with small numbers of cells without use of a homogenization step. The cell pellet (one to three million cells) was suspended in 1.0 ml of TMTriton buffer (50 mM Tris HCl-1.1 mM MgCl2-0.5% Triton X-100), incubated for 5 min at 00, and then centrifuged at 1000 X g for 8 min. This procedure was repeated once. This method for determining nuclear binding gave results equivalent to the homogenizing procedures indicated above. (13) . The columns were equilibrated with 0.015 N NaOH-0.5 M NaCl, and 0.3-0.5 ml of hormone was applied to the column and then eluted with 0.1 N NaOH-5 mM NaCl. Iodide eluted within one column volume, T3 eluted in the second column volume, and T4 eluted in the third column [12I ]T4 was purified by two successive paper chromatographic procedures and used immediately after the last elution (14) . This preparation of [125I]T4 was examined by Sephadex G-25 chromatography and was contaminated with less than 0.8% [1251]T3.
Analysis of Radioactivity Bound to Nuclei. To determine the nature of the nuclear bound radioactivity, nuclei were suspended in 0.015 N NaOH-0.5 M NaCl and applied directly to Sephadex G-25 fine columns. The columns were eluted as described above. This procedure extracted more than 98% of the bound radioactivity, and less than 2% was detected in the excluded volume of the column. Demonstration of Nuclear Receptors by Direct Incubation with Isolated Nuclei. Nuclei were prepared by either of the homogenization procedures indicated above. When they were prepared by centrifugation through 10 ml of 2.2 M sucrose, the nuclei were washed twice in 10 ml of SrMTriton buffer before incubation to remove cytoplasmic contamination. The incubation mixture contained a nuclear suspension equivalent to 20-50 gg of DNA, 0.25 M sucrose, 20 mM Tris1HCl-1.1 mM MgC12 (pH 7.85 at 250), and 2.0 mM, NaEDTA, in 0.9 ml. The incubation mixture was piepared at 00. [12iI]T3 was added to the incubation mixture in 0.1 ml of serum-free Ham's F-10 medium. Hormone binding was studied by incubating the nuclear preparation at 370. At the indicated times, the samples were chilled in an ice bath and then centrifuged at 1000 X g for 8 min. The nuclear pellet was suspended in 1 ml of STM-Triton buffer and centrifuged again. "Specifically" bound hormone in the nuclear pellet was considered to be that which was inhibited by a molar excess (100-200 fold) of nonradioactive hormone.
RESULTS
Binding of TS to Subcellular Components in Intact CeUs. Fig. 1 illustrates the time course of binding of T3 to nuclei, mitochondria, and cytosol isolated after incubation of ['251]T3 with intact cells at 37°. Binding to mitochondria and cytosol occurs very rapidly and approaches an equilibrium within 5-10 min. Binding of T3 to nuclei oceurs more slowly and attains a maximal value only after 2-3 hr of incubation. The kinetics of binding for mitochondria and cytosol at 00 is similar to that determined at 37°. Nuclear binding, however, is completely inhibited at 00 (unpublished data). The time course of T4 binding was similar to that of T3.
It is likely that cells contain multiple binding components of varying affinities for T3 and T4. High-affinity, lowcapacity (saturable) binding sites with an equilibrium dissociation constant similar to the concentration of hormone inducing a half-maximal biologic effect would likely function as hormonal receptors. Low-affinity and high-capacity (nonsaturable) binding sites would likely represent a "nonspecific" interaction. To differentiate between "specific" and "nonspecific" binding to cell components, we calculated R, the ratio of moles of hormone bound to the hormone concentration at equilibrium. R is then plotted againstthe hormone concentration (15) . Theoretically, for saturable binding sites, as the molar concentration of hormone approaches the dissociation constant for the binding protein, the value of R decreases, and as the bound hormone approaches a constant value at saturation, the value of R approaches 0. For high-capacity "nonspecific" binding sites the value of R remains constant with increasing hormone concentrations.
In a typical experiment (Fig. 2) , over a T3 concentration range of 10-12-10-8 M, the value of R remains constant for the mitochondrial and cytosol fractions. The nuclear fraction, however, demonstrates a marked decrease in the value of R up to 1 X 10-10 M. At higher T3 concentrations the value of R tends to level off at a value greater than 0, reflecting binding to high-capacity "nonspecific" sites. in the nuclear fraction are less than those for T3 and the plot of R against the T4 concentration is shifted to the right of the T3 binding curve. This result suggests that the nuclear "receptor" has a lower affinity for T4 than for T3. Fig. 4 illustrates an estimation of the maximal binding capacity and the apparent equilibrium dissociation constants for T3 and T4 determined by the Scatchard method (16 Fig. 3 . Note that the data for T4 was constructed with the six lowest T4 concentrations from Fig. 3 . The values of R for the two highest T4 concentrations were omitted because about 50% of the T4 binding at these concentrations consists of nonspecific, low-affinity, highcapacity binding ( bound at 1 nM (see Fig. 4 ).
Proc.-Nat. Acad. Sci. USA 70 (1973) ii 0I Fig. 4 . The fact that the maximal binding capacity is identical for T4 and T3 and that T3 inhibits T4 nuclear binding suggests that both hormones interact with identical receptor sites in the nucleus.
The Relation Between TS and T4 Nuclear Binding and the Biologic Effect in GHL Cells. Both T3 and T4 exist in bound and free forms in serum, with the free fraction correlating best with biologic activity. The estimated free hormone concentrations inducing a half-maximal increase in the rates of cell growth and glucose utilization are 8 pM for T3 and 100 pM for T4 (5) . These values are slightly lower than the hormone concentrations giving half-maximal nuclear binding.
This may be due to the fact that free hormone concentrations in the biologic studies are estimated by equilibrium dialysis (17) . Therefore, estimated free hormone concentrations may not give an accurate determination of the value in vivo. Nevertheless, the biologic and nuclear binding data are similar enough to suggest that the high-affinity, lowcapacity nuclear binding sites function as cellular receptors and in some way mediate the action of the thyroid hormones. Variability in Nuclear Receptor Content. Glucocorticoid and estrogen in target tissues initially interact with a cytosol receptor (18, 19) . This hormone-receptor complex then binds to specific acceptor sites in the nucleus. The time course of binding of thyroid hormone to cytosol and nuclei (Fig. 1) does not demonstrate a shift of possible cytosol "receptors" to the nucleus. In addition, specific, high-affinity, low-capacity binding sites were not detected in the cytoplasmic fraction but are demonstrated in the nuclear fraction (Fig.  2) . This may result from the fact that a putative cytoplasmic receptor is labile, but when it is transferred to the nucleus as a hormone-receptor complex, it is stable. If the scheme of T3 binding to nuclei in intact cells is similar to that observed for steroids, the number of nuclear receptors is not fixed and should increase after incubation of intact cells with hormone (20) (Fig. 6 ). This result suggests that the number of apparent nuclear receptor sites is not fixed but increases after incubation of intact cells with hormone, possibly from the transfer of an unstable cytoplasmic receptor to the nucleus. of which did not vary by more than 10%. DISCUSSION These studies indicate that GH1 cells contain high-affinity, low-capacity binding sites for both T3 and for T4 in the cell nucleus. The concentrations of T3 and T4 inducing a halfmaximal biologic effect and half-maximal nuclear binding are sufficiently similar to suggest that these nuclear binding sites function as cellular receptors for these hormones. The fact that T4 is converted to T3 in vivo has suggested the possibility that all of the biologic activity of T4 results from its conversion to T3. The recent demonstration of apparent saturable nuclear binding sites for T3 but not for T4 in rat liver, pituitary, and kidney after administration of hormone to intact animals gives additional support to the concept that T4 lacks intrinsic biologic activity (4) . The difficulty in easily detecting high-affinity binding sites for T4 in these in vivo studies may be related to the fact that T4 binding might be obscured by a significant degree of high-capacity, low-affinity binding sites present in nuclei isolated by centrifugation through 2.2 M sucrose. In GH1 cells, high-affinity, low-capacity nuclear binding sites for T4 could not be easily demonstrated unless isolated nuclei were treated twice with buffer containing 0.5% Triton X-100. This procedure solubilizes the outer nuclear membrane as well as any cytoplasmic contamination that would obscure the detection of saturable binding sites for T4 (9) .
"Specific" nuclear binding of T3 is diminished by addition of hormone-depleted serum to an incubation mixture containing either intact cells or isolated nuclei (unpublished data). This finding suggests that "specific" nuclear binding is proportional to the free rather than the bound fraction of hormone in serum. Based on the unbound hormone concentrations, our biologic and nuclear binding studies suggest that on an equimolar basis, T4 has about 1/10 the intrinsic biologic activity of T3. The physiologic concentrations of the thyroid hormones in serum are about 2 nM for T3 and 100 nM for T4, of which greater than 99% is in the bound form (17) .
The relative contribution of T3 and T4 to the total biologic activity of the thyroid hormones in serum is likely dependent on both their relative intrinsic biologic activities as well as on the free hormone concentrations present in serum. The precise concentrations of free T3 and T4 in vivo have not been determined. Estimations by equilibrium dialysis of the percent of total hormone free at physiologic concentrations are about 0.03% for T4 and 0.2-0.4% for T3 (17, 21) .
The calculated free hormone concentrations determined by multiplying the percent free by the total hormone concentration is about 6 bilized a high-affinity T3 binding activity that appears to be an acidic nonhistone protein (unpublished data). The kinetics of binding of [12'I] T3 to this fraction is similar to that observed for isolated nuclei, and the binding is also enhanced by chelating agents. This finding suggests that Na EDTA increases the binding of T3 directly to nuclear receptors rather than alters nuclear membrane permeability.
Our studies in isolated nuclei suggest that the number of nuclear receptors for thyroid hormones is not fixed but increases after incubation of intact cells with T3. These results suggest that the characteristics of binding of the thyroid hormones to nuclear sites may occur by molecular mechanisms similar to that described for estrogens and glucocorticoids in target tissues.
The excellent correlation between the biologic doseresponse relationship and hormone binding to nuclei suggests that these high-affinity nuclear "bindingf sites" play an important role in mediating the action of the thyroid hormones. The localization of the high-affinity binding activity to the cell nucleus supports the concept that the thyroid hormones modulate gene activity.
